Skip to main content
Veterinary Medicines

ANTASTMON, geriamieji milteliai galvijams (veršeliams), arkliams (kumeliukams), kiaulėms (paršeliams) ir šunims

Authorised
  • Trimethoprim
  • Sulfadiazine sodium

Product identification

Medicine name:
ANTASTMON, geriamieji milteliai galvijams (veršeliams), arkliams (kumeliukams), kiaulėms (paršeliams) ir šunims
Active substance:
  • Trimethoprim
  • Sulfadiazine sodium
Target species:
  • Cattle (calf)
  • Horse (foal)
  • Pig (piglet)
  • Dog
Route of administration:
  • Oral use
  • In-feed use
  • In drinking water/milk use

Product details

Active substance and strength:
  • Trimethoprim
    100.00
    milligram(s)
    /
    1.00
    gram(s)
  • Sulfadiazine sodium
    500.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat
        10
        day
    • Horse (foal)
      • Meat
        10
        day
    • Pig (piglet)
      • Meat
        10
        day
    • Dog
  • In-feed use
    • Cattle (calf)
      • Meat
        10
        day
    • Horse (foal)
      • Meat
        10
        day
    • Pig (piglet)
      • Meat
        10
        day
    • Dog
  • In drinking water/milk use
    • Cattle (calf)
      • Meat
        10
        day
    • Horse (foal)
      • Meat
        10
        day
    • Pig (piglet)
      • Meat
        10
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01EW10
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/98/0739/001-003
Date of authorisation status change:

Documents

RV0739.pdf

Lithuanian (PDF)
Published on: 3/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."